Precision oncology, or the clinically and financially efficient use of genomically matched treatments and clinical trials, is evolving as a potentially important starting point for cancer care within successful alternative payment models.
Ingrid Marino, MS, CGC
Advertisement
Articles by Ingrid Marino, MS, CGC
Advertisement
Latest Updated Articles
- Precision Oncology: Why Payers Should Initiate CGP Coverage Now!
Published: August 19th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
3
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
4
Real-World Evidence Supports Switch to Next-Generation BTK Inhibitor for CLL: A Q&A With Margaret Krackeler, MD
5